Seres Therapeutics, Inc.MCRBNASDAQ
Loading
Enterprise value to EBITDA ratio
Latest
-1.88
↑ 67% vs avg
Percentile
P77
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
-5.64
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -1.88 | -19.1% |
| 2024 | -1.58 | -14.6% |
| 2023 | -1.38 | +61.0% |
| 2022 | -3.54 | +68.3% |
| 2021 | -11.16 | +54.1% |
| 2020 | -24.31 | -763.3% |
| 2019 | -2.82 | -142.9% |
| 2018 | -1.16 | +75.1% |
| 2017 | -4.66 | -17.9% |
| 2016 | -3.96 | - |